Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Unisal is a brand of normal saline (0.9% w/v sodium chloride) intravenous infusion developed and manufactured by Unique Pharmaceutical Laboratories. It is indicated for extracellular fluid and electrolyte replacement in clinical conditions such as dehydration, hypovolemia, hemorrhage, and sepsis. It is also used to treat metabolic alkalosis associated with fluid loss, mild sodium depletion, as a priming solution in hemodialysis, and to initiate or terminate blood transfusions. Additionally, it serves as a pharmaceutical vehicle and diluent for the infusion of compatible drug additives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride (Unique Pharmaceutical Laboratories Limited).